Average Annual Drug Cost and its Determinants in a Population Based Cohort of HIV—Positive Adult Men and Women

[1]  Mike Youle,et al.  Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection , 1997, PharmacoEconomics.

[2]  R. Chaisson,et al.  Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[3]  S. Petrou.  Current Controversies in the Treatment of HIV Infection and AIDS , 1996, PharmacoEconomics.

[4]  Richard D Moore,et al.  Combination Antiretroviral Therapy in HIV Infection , 1996, PharmacoEconomics.

[5]  D. Ward,et al.  Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[6]  J. Carlin,et al.  The usage and costs of health services for HIV infection in Australia , 1995, AIDS.

[7]  F J Hellinger,et al.  The lifetime cost of treating a person with HIV. , 1993, JAMA.

[8]  K. Tolley,et al.  The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe. , 1993, Health policy.

[9]  L. Lynn,et al.  Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection. , 1991, Annals of internal medicine.

[10]  A M Epstein,et al.  Effect of changing patterns of care and duration of survival on the cost of treating the acquired immunodeficiency syndrome (AIDS). , 1990, American journal of public health.

[11]  A. Scitovsky.  Studying the cost of HIV-related illnesses: reflections on the moving target. , 1989, The Milbank quarterly.

[12]  P. Albert,et al.  Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.

[13]  G. Carliner,et al.  The economic impact of AIDS in the United States. , 1988, Science.

[14]  P. Lee,et al.  Medical care costs of patients with AIDS in San Francisco. , 1986, JAMA.

[15]  J. Curran,et al.  The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. , 1986, JAMA.

[16]  K. Simpson.  Design and assessment of cost-effectiveness studies in AIDS populations. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[17]  H. Morgenstern,et al.  Impact of immunosuppression on health care use by men in the Multicenter AIDS Cohort Study (MACS). , 1994, Journal of acquired immune deficiency syndromes.

[18]  S L Zeger,et al.  Regression analysis for correlated data. , 1993, Annual review of public health.

[19]  D. Rice,et al.  Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. , 1987, Public health reports.

[20]  Rice Dp,et al.  Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. , 1988, The Journal of medical practice management : MPM.

[21]  Joseph P. Newhouse,et al.  The Economics of Moral Hazard , 1969 .